NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
BRENUS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BRENUS PHARMA
ST13
US500000098365795Class
42
Filing
98365795
Registration
7701543
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
02/25/2025
Trademark type
Word
Nice classes
42
Filing date
01/19/2024
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Clermont-Ferrand, FR
Examiner
LAMONT, MIAH
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
B. P. (pessoa física)
Representatives
Pina Campagna Carter, DeLuca, and Farrell, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Cell culture services for scientific and research purposesfor others; Chemicalbiochemicalbiological and bacteriological research and analysis; Development and establishment of testing specifications and procedures in the field of medicine; Medical and scientific research in the field of pharmacology; Medical research laboratory services; Medical research laboratory services in the field of oncology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research information in the field of pharmaceuticals; Providing scientific information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research and development in the field of immunotherapy; Research and development in the field of oncology; Research and development in the field of biotechnological and pharmaceutical drugs; Research and development in the field of advanced therapy drugs; Research and development in the field of pharmaceuticals; Research in the field of cell engineering technology; Scientific laboratory services; Scientific research for medical purposes in the field of immunotherapy
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2024
ALIE
ASSIGNED TO LIE
11/12/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/28/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/20/2024
GNSL
LETTER OF SUSPENSION E-MAILED
08/20/2024
CNSL
SUSPENSION LETTER WRITTEN
08/20/2024
DOCK
ASSIGNED TO EXAMINER
08/14/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/25/2024
NWAP
NEW APPLICATION ENTERED
01/19/2024
Continuous trademark protection
Get notified about every new filing that threatens BRENUS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.